Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Brain Metastases Management: From Detection to Multidisciplinary Care
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
1.00 program credit
- Barbara O'Brien, MD
1.00 program credit
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Enriqueta Felip, MD
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Barbara O'Brien, MD; Nadia Harbeck, MD, PhD
1.00 program credit
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credit
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD; Melin Khandekar, MD, PhD
1.00 program credit
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credit
CME/CE In-Person Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
Chicago, Illinois
1.50 credits
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
CME/CE Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
07:30 PM - 09:00 PM ET
1.50 credits
CME/CE In-Person & Virtual Event
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
May 30, 2026
Chicago, Illinois
1.50 credits
Making Mechanism-Based Treatment Decisions in cGVHD
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®
Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP; Alicia Lieberman, MD, MS
- Brian P. McDonough, MD, FAAFP
- Alicia Lieberman, MD, MS

Medical News

Medical News
FDA Approves Vepdegestrant for ESR1-Mutated Advanced Breast Cancer
05/05/2026
Read more
Medical News
CRC Screening: FIT-DNA vs FIT Outreach in Community Care
05/04/2026
Read more
Medical News
AI as a Third Reader in Breast Cancer Screening
05/04/2026
Read more
Medical News
ASCENT-04 Results for Frontline PD-L1+ TNBC
04/30/2026
Read more

CME/CE

Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CE
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
0.25 credits
- Barbara O'Brien, MD
0.25 credits
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Barbara O'Brien, MD; Nadia Harbeck, MD, PhD
1.00 program credit
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credit
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Benjamin Levy, MD; Melin Khandekar, MD, PhD
1.00 program credit
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credit
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CE
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
0.25 credits
- Cem Akin, MD, PhD
0.25 credits

Clinical Practice

MinuteCE®
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
Barbara O'Brien, MD; Benjamin Levy, MD
1.00 credit 6 episodes
- Barbara O'Brien, MD
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
- Nadia Harbeck, MD, PhD
1.00 credit 6 episodes
Managing Brain Metastases Through Multidisciplinary Team Collaboration
Managing Brain Metastases Through Multidisciplinary Team Collaboration
MinuteCE®
Managing Brain Metastases Through Multidisciplinary Team Collaboration
Benjamin Levy, MD
1.00 program credit
- Benjamin Levy, MD
1.00 program credit
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP; Madison Conces, MD
- Brian P. McDonough, MD, FAAFP
- Madison Conces, MD
- Midhun Malla, MD
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
- Raghava Reddy Induru, MD

Programs

Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
- Raghava Reddy Induru, MD
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP; Guru P. Sonpavde, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Guru P. Sonpavde, MD
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's Roundtable
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
- Mallik Greene, PhD
The Stepping Stones to Better Colorectal Cancer Screening
The Stepping Stones to Better Colorectal Cancer Screening
Clinician's Roundtable
The Stepping Stones to Better Colorectal Cancer Screening
Harish Gagneja, MD
- Harish Gagneja, MD